TrialBritish journal of cancer2017

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.

P-E Heudel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.